GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Can Fite Biofarma Ltd (AMEX:CANF) » Definitions » PS Ratio
中文

Can Fite Biofarma (Can Fite Biofarma) PS Ratio

: 11.19 (As of Today)
View and export this data going back to 2012. Start your Free Trial

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Can Fite Biofarma's share price is $1.98. Can Fite Biofarma's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.18. Hence, Can Fite Biofarma's PS Ratio for today is 11.19.

Warning Sign:

Can Fite Biofarma Ltd stock PS Ratio (=13) is close to 1-year high of 13

The historical rank and industry rank for Can Fite Biofarma's PS Ratio or its related term are showing as below:

CANF' s PS Ratio Range Over the Past 10 Years
Min: 0.92   Med: 28.19   Max: 715.71
Current: 8.68

During the past 13 years, Can Fite Biofarma's highest PS Ratio was 715.71. The lowest was 0.92. And the median was 28.19.

CANF's PS Ratio is ranked better than
50.65% of 993 companies
in the Biotechnology industry
Industry Median: 8.93 vs CANF: 8.68

Can Fite Biofarma's Revenue per Sharefor the three months ended in Dec. 2023 was $0.03. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.18.

Warning Sign:

Can Fite Biofarma Ltd revenue per share has been in decline for the last 5 years.

During the past 12 months, the average Revenue per Share Growth Rate of Can Fite Biofarma was -50.00% per year. During the past 3 years, the average Revenue per Share Growth Rate was -37.00% per year. During the past 5 years, the average Revenue per Share Growth Rate was -63.90% per year.

During the past 13 years, Can Fite Biofarma's highest 3-Year average Revenue per Share Growth Rate was 139.10% per year. The lowest was -74.70% per year. And the median was -46.25% per year.

Back to Basics: PS Ratio


Can Fite Biofarma PS Ratio Historical Data

The historical data trend for Can Fite Biofarma's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Can Fite Biofarma Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PS Ratio
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.16 24.88 24.50 21.00 13.00

Can Fite Biofarma Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
PS Ratio Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.00 7.00 9.75 8.25 13.00

Competitive Comparison

For the Biotechnology subindustry, Can Fite Biofarma's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Can Fite Biofarma PS Ratio Distribution

For the Biotechnology industry and Healthcare sector, Can Fite Biofarma's PS Ratio distribution charts can be found below:

* The bar in red indicates where Can Fite Biofarma's PS Ratio falls into.



Can Fite Biofarma PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

Can Fite Biofarma's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=1.98/0.177
=11.19

Can Fite Biofarma's Share Price of today is $1.98.
Can Fite Biofarma's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.18.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


Can Fite Biofarma  (AMEX:CANF) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


Can Fite Biofarma PS Ratio Related Terms

Thank you for viewing the detailed overview of Can Fite Biofarma's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Can Fite Biofarma (Can Fite Biofarma) Business Description

Traded in Other Exchanges
Address
10 Bareket Street, Kiryat Matalon, P.O. Box 7537, Petah-Tikva, ISR, 4951778
Can Fite Biofarma Ltd is an advanced clinical stage drug development company with a platform technology that is designed to address multi-billion dollar markets in the treatment of cancer, liver, and inflammatory disease. The company's lead drug candidate, Piclidenoson, is currently in a Phase III trial for psoriasis. Can-Fite's liver drug, Namodenoson, is headed into a Phase III trial for hepatocellular carcinoma (HCC), the most common form of liver cancer, and a Phase IIb trial for the treatment of non-alcoholic steatohepatitis (NASH).

Can Fite Biofarma (Can Fite Biofarma) Headlines

From GuruFocus